Jeffrey Lawrence Schwartz
CIK: 0001702957
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
Director10% Owner
Discretionary Trading P&L
Holdings
About Schwartz Jeffrey Lawrence
Schwartz Jeffrey Lawrence (SEC CIK 0001702957) files insider reports with the SEC as Director of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
Signal8 holds 3 ownership filings by Schwartz Jeffrey Lawrence (1 Form 3, 2 Form 4), filed between Mar 6, 2025 and Sep 10, 2026. Those filings report 3 transactions, from Sep 4, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schwartz Jeffrey Lawrence's filings is in BOSTON, MA.
Recent filings by Schwartz Jeffrey Lawrence
Other insiders filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
- Mahboob Vaseem, Chief Financial Officer
- Umberger Traci S
- Webster Brian Daniel
- COHEN RAYMOND W, Director
- Kwo Elizabeth, Director
- Hanley Conor, Director